semaglutide micro dosing Microdosing Semaglutide: The Gentle GLP-1 Option The Benefits of Micro-Dosing GLP-1

If you're in Washington with a BMI of 30 or higher, or 27 with a weight-related medical condition like hypertension, type 2 diabetes, or high cholesterol, you might be a candidate for semaglutide weight loss

Understanding your individual metabolic profileincluding genetic predispositions in glucose regulation, insulin sensitivity, and GLP-1 pathway responsivenesscan support a more informed conversation with your provider about whether dual-therapy protocols align with your clinical picture and goals

Brzoska T, Luger TA, Maaser C, Abels C, Bohm M

Known as the "Triple G," it targets three vital metabolic pathways: the GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and GCG (Glucagon) receptors